Methamphetamine use is associated with more than twice the risk for dropping out of treatment for opioid-use disorder, according to a new study from the University of Washington. The research team was led by Dr. Judith Tsui from UW Medicine and included Dr. Brian Leroux, professor of biostatistics at the University of Washington School of Public Health.
The team conducted a large study at three sites in Washington state – Harborview Adult Medicine Clinic in Seattle and Evergreen Treatment Services in Olympia and Grays Harbor. Findings were published online Oct. 26 in the Journal of Substance Abuse Treatment.
It is not known exactly why it’s harder for people with these co-addictions to stay in treatment for opioid-use disorder, but Dr. Tsui said that many of these patients experience major challenges in their day-to-day lives.Friday Letter Submission, Publish on January 03